Stericycle

Stericycle, Inc. engages in the provision of waste management services. It operates through the following segments: North America and International. The North America and International segments offer the following services: Regulated Waste and Compliance Services (RWCS), Secure Information Destruction Services (SID), Communication and Related Services (CRS). The RWCS provides collection and processing of regulated and specialized waste, including medical (including reusable sharps disposal management services), pharmaceutical and hazardous waste, for disposal and compliance programs. The SID provides a collection of personal and confidential information for secure destruction and recycling of shredded paper. The CRS includes communication services such as appointment reminders, secure messaging, event registration and other communications for hospitals and IDN’s. The company was founded by James W. Sharp in March 1989 and is headquartered in Lake Forest, IL.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Stericycle reports robust Q4 performance and outlines growth strategies

Stericycle's Q4 2022 showcased strong financial performance and strategic initiatives for growth and efficiency.
Guidance for 2023 outlines organic revenue growth, adjusted EPS range, and debt reduction targets, positioning the company for continued success.
Despite challenges from ERP rollout impact and macroeconomic factors, Stericycle's focus on operational improvements and revenue growth presents opportunities for long-term value creation.

Stericycle reports robust Q1 performance, eyes growth amid challenges

Stericycle's Q1 performance reflects strong revenue growth and margin expansion, supported by operational efficiency and strategic divestitures.
While facing challenges such as inflation impacts and debt management, the company is well-positioned to capitalize on opportunities like capital deployment and revenue growth drivers.
Overall, Stericycle's focus on operational excellence, financial discipline, and strategic investments sets a positive trajectory for sustainable growth and profitability.

Stericycle achieves debt reduction targets amidst revenue growth challenges

Stericycle's Q2 performance reflects progress in debt reduction, operational efficiency, and revenue growth despite challenges in certain segments.
Strategic divestments, infrastructure projects, and commitment to guidance demonstrate resilience and adaptability in a changing market landscape.
Addressing challenges in Secure Information Destruction and ERP implementation while capitalizing on opportunities for further divestments and operational improvements will be key for future success.

Stericycle reports positive Q3 earnings, eyes ERP enhancements for growth

Stericycle's Q3 performance showcased growth in regulated waste services and adjustments in financial guidance.
The company's focus on ERP enhancements, legacy system optimization, and workforce reductions positions it for future success.
Challenges in Secure Information Destruction revenue and national account impacts are being addressed for long-term growth.
Opportunities lie in improving operational efficiency, customer engagement, and capitalizing on stable national account trends.

Stericycle reports solid Q4 performance, eyes growth through acquisitions

Stericycle's Q4 2023 performance showcased revenue growth, margin expansion, and operational efficiency efforts, driving a focus on profitable growth and financial discipline.
The company's strengths lie in ESG initiatives, regional positioning, technology utilization, and construction progress, offering a foundation for strategic growth and sustainability.
Challenges include cash flow impacts, analyst inquiries, portfolio optimization hurdles, and market headwinds, which Stericycle aims to address through strategic planning and execution.
Opportunities for Stericycle include organic revenue growth, acquisitions, cash flow optimization, and operational enhancements, positioning the company for continued success and resilience.

Stericycle reports improved Q1 earnings amidst pricing challenges and growth opportunities

Stericycle's Q1 2024 showcased improved financial performance driven by revenue growth in key segments, despite challenges from pricing headwinds and commodity indexed revenues.
The company's focus on workforce optimization, operational enhancements, and a transition to a subscription-based model presents growth opportunities and margin expansion potential.
While facing challenges in certain revenue streams, Stericycle's strategic initiatives and commitment to diversity and inclusion position it well for future growth and profitability.
Overall, Stericycle's Q1 performance reflects a balanced approach to addressing challenges, leveraging strengths, and capitalizing on opportunities for sustained growth and success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The appointment of a new CFO can't outweigh pessimism over a sales miss and a big GAAP loss.

Why Stericycle Stock Slumped 15%

Lower revenues, higher operating costs, extreme weather conditions, increase in interest expenses and higher effective tax rate hurt Stericycle's (SRCL) first-quarter 2019 results.

Stericycle (SRCL) Posts Disappointing Q1 Earnings, Stock Down

Stericycle's (SRCL) CEO Cindy Miller on Q1 2019 Results - Earnings Call Transcript

Stericycle (SRCL) delivered earnings and revenue surprises of -34.48% and -3.94%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Stericycle (SRCL) Q1 Earnings and Revenues Miss Estimates

Weakness in Communication and Related Services and SQ (small quantity) pricing pressure are expected to weigh on Stericycle's (SRCL) first-quarter 2019 results.

Stericycle (SRCL) Q1 Earnings to Reflect SQ Pricing Pressure

Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Stericycle (SRCL) Q1 Earnings Expected to Decline

Stericycle (SRCL) reported earnings 30 days ago. What's next for the stock?

Stericycle (SRCL) Up 22.1% Since Last Earnings Report: Can It Continue?

News for Stericycle Stock (SRCL)